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Zaidan et al. (2014) recently identified solid renal tumors
by sonographic scanning among 170 patients in Parisian
renal disorder programs who had been treated with lith-
ium for an average of 21.4 years and developed de-
creased renal function. In such patients, the observed
rate of renal tumors was high, at 14/170 (8.24%), and
half of the tumors were considered malignant (4.12%).
The observed rate of solid renal tumors was nearly six
times greater than among patients with chronic renal
disease (matched for age, sex, and glomerular filtration
rate) but not known to have been exposed to lithium
(8.24% vs. 5/340 or 1.47%), and the risk among all ob-
served patients with renal dysfunction (19/510 or 2.73%)
was over three times less than with lithium treatment
(2.73% vs. 8.24%). These rates were reported to be far
greater than in the general population. However, risks
among lithium-treated patients without renal impair-
ment were not reported. The report proposes that there
is an increased risk of renal tumors in association with
long-term exposure to lithium salts among patients with
impaired renal function.
These striking observations, if validated, are of consid-
erable concern, particularly as long-term treatment with
lithium has been associated with risk of pathological and
pathophysiological changes in renal function that call for
regular, routine clinical monitoring of indices of renal
function among patients treated long-term with lithium
(Bauer et al. 2006; Baldessarini 2013). Rates of severe
impairment of renal function among lithium-treated pa-
tients may be as low as 0.5% (McKnight et al. 2012).
Given an estimated risk of solid renal tumors of 8.24%
(and of malignancies of about 4.12%) of lithium-treated
patients with significant renal impairment (Zaidan et al.
2014), a tentative estimate of risk of kidney tumors
among all patients exposed to lithium long-term would
be approximately 0.041% (0.0824 × 0.005), and of cancers* Correspondence: rbaldessarini@mclean.harvard.edu
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reproduction in any medium, provided the origof about 0.020%. This estimate suggests a risk of one
case of solid renal tumor in approximately 2,400
lithium-treated patients or of a malignancy in approxi-
mately 4,800 lithium-treated patients. These rates indi-
cate that large samples will be required to evaluate risks
among lithium-treated patients. These and other medical
risks are to be balanced against the extraordinary body
of evidence that lithium, more than any other mood
stabilizer, not only has short-term antimanic effects but
can also reduce risks of recurrences of various compo-
nents of bipolar disorder and may reduce the risks of
suicide as well as of mortality associated with cardiovas-
cular and respiratory illnesses, which are more frequent
in bipolar patients compared to the general population
(Bauer et al. 2006; Ahrens et al. 1995; Baldessarini et al.
2006; Grof and Müller-Oerlinghausen 2009).
The preceding considerations suggest that the findings
reported by Zaidan et al. (2014) require further study,
ideally in large samples of patients exposed to lithium
treatment, stratified for renal functional status, lithium
exposure, and perhaps age. Clinically, the findings
underscore the importance of close medical monitoring
of patients treated with lithium, especially for more than
several years, and consideration of renal scanning exami-
nations for cysts and tumors among those with clinically
identified, progressive impairment of renal function. Our
impression, based on consulting international colleagues
who lead large mood disorder clinical programs, is that
no reports of renal cancers have emerged in a collective
experience involving thousands of psychiatric patients
treated long-term with lithium (IGSLI centers, www.
igsli.org; personal written communication, 28 March
2014; and clinical records of the Lucio Bini Mood Disor-
ders Centers, Rome and Cagliari, March 2014). Never-
theless, in view of the potential seriousness of the new
findings, it would be of interest to organize an inter-
national, register-based, cohort study to investigate the
hypothesis that the risk of renal tumors is increased
among patients exposed to lithium, including iner. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
inal work is properly credited.
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